1,131 results on '"Kullberg, Bart-Jan"'
Search Results
102. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus group
103. Tailored interventions to improve antibiotic use for lower respiratory tract infections in hospitals: a cluster-randomized, controlled trial
104. Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor
105. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance
106. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors
107. Proinflammatory Cytokines in the Treatment of Bacterial and Fungal Infections
108. A Multidisciplinary Approach to Fungal Infections: One-Year Experiences of a Center of Expertise in Mycology
109. 147. Clinical Safety and Efficacy of Novel Antifungal, Fosmanogepix, in the Treatment of Candidemia: Results from a Phase 2 Proof of Concept Trial
110. 1157. Clinical Safety, Efficacy, and Pharmacokinetics of Fosmanogepix, a Novel First-in-class Antifungal, in Patients with Renal Insufficiency: Subset Analysis from a Phase 2 Candidemia Trial
111. Phagocytosis and Intracellular Killing of Candida albicans by Murine Polymorphonuclear Neutrophils
112. Design of efficacy trials of cytokines in combination with antifungal drugs
113. An elevated pro-inflammatory cytokine response is linked to development of amphotericin B-induced nephrotoxicity
114. Genetic susceptibility to Candida infections
115. Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factoralpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance Center.
116. Treatment of candidiasis: insights from host genetics
117. Cross-tolerance and priming between C-type lectin receptors and TLRs: PS2-102
118. STAT1 Mutations in Autosomal Dominant Chronic Mucocutaneous Candidiasis
119. Immune response to Aspergillus fumigatus in compromised hosts: from bedside to bench
120. An Exaggerated Monocyte-Derived Cytokine Response to Candida Hyphae in Patients With Recurrent Vulvovaginal Candidiasis
121. Differential susceptibility to lethal endotoxaemia in mice deficient in IL-1α, IL-1β or IL-1 receptor type I
122. The Candida Th17 response is dependent on mannan- and β-glucan-induced prostaglandin E2
123. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
124. Appropriate empirical antibiotic use in the emergency department: full compliance matters!
125. Clinical Outcome of Antibiotic Suppressive Therapy in Patients with a Prosthetic Joint Infection after Hip Replacement
126. Cognitive impairments in patients with persistent symptoms attributed to Lyme disease
127. Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity
128. Genomewide Association Study of Leprosy
129. Dectin-1 Deficiency and Mucocutaneous Fungal Infections
130. Caspase-1, but not ASC or NLRP3 inflammasome components, mediates IL-1beta activation and antifungal defense in disseminated candidiasis
131. Summary and comments
132. Functional consequences of the Asp299Gly Toll-like receptor-4 polymorphism
133. Cytokine production of stimulated whole blood cultures in rheumatoid arthritis patients receiving short-term infliximab therapy
134. Effects of Hydrophobicity on the Antifungal Activity of α-Helical Antimicrobial Peptides
135. Crohnʼʼs disease patients homozygous for the 3020insC NOD2 mutation have a defective NOD2/TLR4 cross-tolerance to intestinal stimuli
136. Barriers to optimal antibiotic use for community-acquired pneumonia at hospitals: a qualitative study
137. Improving the quality of antimicrobial drug use can result in cost containment
138. Immune recognition of candida albicans (beta)-glucan by dectin-1
139. Toll-like receptor 2 controls expansion and function of regulatory T cells
140. Cytokines in the treatment of fungal infections
141. Interleukin-1 and related pro-inflammatory cytokines in the treatment of bacterial infections in neutropenic and non-neutropenic animals
142. Immunomodulators in Bacterial and Fungal Infections: A Review of Their Therapeutic Potential
143. Quality improvement of surgical prophylaxis in Dutch hospitals: evaluation of a multi-site intervention by time series analysis
144. Introduction: Cytokines in the biotherapy of infectious diseases
145. Understanding variation in quality of antibiotic use for community-acquired pneumonia: effect of patient, professional and hospital factors
146. Endogenous Interleukin (IL)-1 (alpha) and IL-1 (beta) are crucial for host defense against disseminated candidiasis
147. Toll-like receptors as an escape mechanism from the host defense
148. Improving the Process of Antibiotic Therapy in Daily Practice: Interventions to Optimize Timing, Dosage Adjustment to Renal Function, and Switch Therapy
149. No effect of recombinant human interleukin-1 on numbers of peripheral blood and peritoneal leukocytes during acute inflammation
150. Selective regulation of intercellular adhesion molecule-1 expression by interleukin-18 and interleukin-12 on human monocytes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.